About Careers Internship MedBlog Contact us

Combined Lumacaftor-Ivacaftor Therapy: Safe and Effective for Cystic Fibrosis Patients

by Bidita Debnath on May 18, 2015 at 3:33 PM
Combined Lumacaftor-Ivacaftor Therapy: Safe and Effective for Cystic Fibrosis Patients

Cystic fibrosis, a genetic disease that causes the body to create thick and sticky mucus, can now be controlled, thanks to a new breakthrough research.

In an international clinical trial, treatment with two medications, which targeted the most common genetic cause of cystic fibrosis, improved lung function and lowered the rate of pulmonary exacerbations.


The Combined Lumacaftor-Ivacaftor Therapy was shown to be safe and effective for cystic fibrosis patients.

The mucus formed due to this disease leads to chronic infections and increased loss of lung function. In the pancreas, the thick mucus keeps enzymes from reaching the gut to digest food. The median life expectancy is 37 years, and available treatments mostly focus on managing symptoms and consequences of the disease.

McColly, an Associate Director at the Cystic Fibrosis Center at Lurie Children's said, while significant progress has been made with supportive therapies for cystic fibrosis, developing treatments that address the underlying genetic cause still is a challenge.

The research claims that combining Ivacaftor with Lumacaftor helps patients with the most common cystic fibrosis mutation.

The study is published in the New England Journal of Medicine.

Source: ANI
Font : A-A+



Recommended Readings

Latest Research News

Brain Circuits That Shape Bedtime Rituals in Mice
New study sheds light on the intrinsic, yet often overlooked, role of sleep preparation as a hardwired survival strategy.
NELL-1 Protein Aids to Reduce Bone Loss in Astronauts
Microgravity-induced bone loss in space, can be reduced by systemic delivery of NELL-1, a protein required for bone growth and its maintenance.
Connecting Genetic Variants to the Alzheimer's Puzzle
Researchers establish connections between Alzheimer's-linked genetic alterations and the functioning of brain cells.
Gene Therapy Sparks Spinal Cord Regeneration
Team at NeuroRestore introduces a groundbreaking gene therapy that has effectively promoted nerve regrowth and reconnection, post spinal cord injury.
Unlocking the Gut Microbiome's Influence on Bone Density
Scientists aim to pinpoint particular functional pathways affected by these bacteria that may have an impact on skeletal health.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
Greetings! How can I assist you?MediBot

Combined Lumacaftor-Ivacaftor Therapy: Safe and Effective for Cystic Fibrosis Patients Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests